Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 888,066
  • Shares Outstanding, K 20,133
  • Annual Sales, $ 41,590 K
  • Annual Income, $ 9,330 K
  • 60-Month Beta -0.10
  • Price/Sales 19.26
  • Price/Cash Flow 60.81
  • Price/Book 5.59
Trade SLP with:

Options Overview

Details
  • Implied Volatility 46.10%
  • Historical Volatility 31.58%
  • IV Percentile 13%
  • IV Rank 30.80%
  • IV High 75.07% on 11/05/20
  • IV Low 33.20% on 09/15/21
  • Put/Call Vol Ratio 6.00
  • Today's Volume 21
  • Volume Avg (30-Day) 22
  • Put/Call OI Ratio 1.40
  • Today's Open Interest 173
  • Open Int (30-Day) 181

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 08/31/21
See More
  • Average Estimate 0.08
  • Number of Estimates 2
  • High Estimate 0.09
  • Low Estimate 0.07
  • Prior Year 0.12
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.74 +4.70%
on 08/19/21
47.29 -7.59%
on 09/02/21
-0.36 (-0.82%)
since 08/17/21
3-Month
41.74 +4.70%
on 08/19/21
57.27 -23.69%
on 07/01/21
-11.33 (-20.59%)
since 06/17/21
52-Week
41.74 +4.70%
on 08/19/21
90.92 -51.94%
on 02/08/21
-21.15 (-32.61%)
since 09/17/20

Most Recent Stories

More News
Simulations Plus Releases ADMET Predictor(R) (X.3)

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has...

SLP : 43.70 (-0.93%)
Simulations Plus to Participate in BofA Securities and Oppenheimer Investor Conferences

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that chief executive officer Shawn O'Connor...

SLP : 43.70 (-0.93%)
Simulations Plus Reports Continued Success in Second Phase of AIDD Collaboration with Large Pharmaceutical Company

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has received the second phase of...

SLP : 43.70 (-0.93%)
NMPA's Center for Drug Evaluation Adds Licenses of GastroPlus(R)

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has...

SLP : 43.70 (-0.93%)
PepsiCo, Nokia rise; Boeing, Conagra fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Tuesday:

SLP : 43.70 (-0.93%)
FAST : 52.96 (-1.03%)
MNR : 18.84 (-1.10%)
FTV : 72.74 (-1.98%)
BA : 213.36 (unch)
PEP : 154.13 (-0.92%)
Simulations Plus (SLP) Q3 Earnings Top, Revenues Miss Estimates

Simulations Plus (SLP) Q3 results are hurt by weakness in Services business, stemming from project delays. Software business revenues witness strong growth.

INTU : 561.85 (-1.93%)
JBL : 60.89 (-3.27%)
SLP : 43.70 (-0.93%)
ZM : 287.68 (+3.40%)
Simulations Plus: Fiscal Q3 Earnings Snapshot

LANCASTER, Calif. (AP) _ Simulations Plus Inc. (SLP) on Monday reported fiscal third-quarter net income of $3.8 million.

SLP : 43.70 (-0.93%)
Simulations Plus Reports Third Quarter Fiscal 2021 Financial Results

--Board of Directors announces quarterly dividend of $0.06 per share

SLP : 43.70 (-0.93%)
Housing Starts, Wholesale Trade Featured in Canada Next Week

Monday U.S. Featured Earnings Simulations Plus, Inc. (NASDAQ: SLP) (Q3) EPS projected for 17 cents, ...

SLP : 43.70 (-0.93%)
ASLN : 3.22 (+6.27%)
JPM : 157.68 (-0.26%)
PEP : 154.13 (-0.92%)
WFC : 46.47 (+0.41%)
GS : 391.46 (-1.32%)
BAC : 40.50 (+0.12%)
C : 69.96 (-0.06%)
BLK : 876.63 (-1.55%)
TSM : 117.75 (-2.52%)
UNH : 420.16 (+0.80%)
MS : 101.75 (-0.70%)
SCHW : 70.43 (-0.49%)
HDB : 74.20 (-0.96%)
ERIC : 11.28 (-2.84%)
ATZ.TO : 42.50 (-1.41%)
TMQ.TO : 2.46 (-0.81%)
Simulations Plus (SLP) to Post Q3 Earnings: What's in Store?

Simulations Plus (SLP) fiscal third-quarter performance is likely to reflect gains from strength in its diversified portfolio that includes offerings like GastroPlus, DDDPlus and PKPlus.

TXN : 196.25 (-0.29%)
AAPL : 146.06 (-1.83%)
STX : 83.74 (-1.27%)
SLP : 43.70 (-0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab,...

See More

Key Turning Points

3rd Resistance Point 45.76
2nd Resistance Point 45.19
1st Resistance Point 44.45
Last Price 43.70
1st Support Level 43.14
2nd Support Level 42.57
3rd Support Level 41.83

See More

52-Week High 90.92
Fibonacci 61.8% 72.13
Fibonacci 50% 66.33
Fibonacci 38.2% 60.53
Last Price 43.70
52-Week Low 41.74

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar